Literature DB >> 10820158

Analysis of tissue chimerism in nude mouse brain and abdominal xenograft models of human glioblastoma multiforme: what does it tell us about the models and about glioblastoma biology and therapy?

L Antunes1, K S Angioi-Duprez, S R Bracard, N A Klein-Monhoven, A E Le Faou, A M Duprez, F M Plénat.   

Abstract

In situ hybridization coupled to immunohistochemistry for antigens of interest allows unequivocal identification of tumor cells from reactive stroma cells and normal adjacent structures in human glioblastoma multiforme grafts transplanted into nude mice. With this methodology, we have explored the development of glioblastoma multiforme solid grafts transplanted into nude mouse brains or flanks. The brain transplants closely resembled the human situation, particularly in relation to differentiation and growth patterns. The morphological features of peritumoral reactive gliosis were similar to those observed in humans. A mouse glial stroma within the main tumor masses was also demonstrated. Kinetic studies showed that the compartment of isolated tumor cells that infiltrated host brains and the reactive gliosis constituted two cycling cell populations. Despite VEGF protein expression by tumor cells and some reactive astrocytes, the abnormally permeable microvascular beds were not hyperplastic. The observation of a non-infiltrative pattern of growth when grafts were established in host flanks demonstrated that the organ-specific environment plays a determining role in the growth and invasive properties of glioblastoma. The phylogenetic distance between man and mouse and the recipient immunoincompetence should not impose serious limitations on the use of this model for studying malignant glioma biology and therapy in vivo.

Entities:  

Mesh:

Year:  2000        PMID: 10820158     DOI: 10.1177/002215540004800613

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma.

Authors:  Rachael A Vaubel; Shulan Tian; Dioval Remonde; Mark A Schroeder; Ann C Mladek; Gaspar J Kitange; Alissa Caron; Thomas M Kollmeyer; Rebecca Grove; Sen Peng; Brett L Carlson; Daniel J Ma; Gobinda Sarkar; Lisa Evers; Paul A Decker; Huihuang Yan; Harshil D Dhruv; Michael E Berens; Qianghu Wang; Bianca M Marin; Eric W Klee; Andrea Califano; Daniel H LaChance; Jeanette E Eckel-Passow; Roel G Verhaak; Erik P Sulman; Terry C Burns; Fredrick B Meyer; Brian P O'Neill; Nhan L Tran; Caterina Giannini; Robert B Jenkins; Ian F Parney; Jann N Sarkaria
Journal:  Clin Cancer Res       Date:  2019-12-18       Impact factor: 12.531

2.  Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Authors:  Caterina Giannini; Jann N Sarkaria; Atsushi Saito; Joon H Uhm; Evanthia Galanis; Brett L Carlson; Mark A Schroeder; C David James
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

Review 3.  Therapeutic Hypothesis Testing With Rodent Brain Tumor Models.

Authors:  Derek A Wainwright; Craig M Horbinski; Rintaro Hashizume; C David James
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

4.  Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar.

Authors:  Xi Feng Fei; Quan Bin Zhang; Jun Dong; Yi Diao; Zhi Min Wang; Ru Jun Li; Zi Cheng Wu; Ai Dong Wang; Qing Lan; Shi Ming Zhang; Qiang Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-06-29

5.  Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?

Authors:  Stéphane Kremer; Sophie Pinel; Pierre-Olivier Védrine; Aude Bressenot; Philippe Robert; Serge Bracard; François Plénat
Journal:  J Neurooncol       Date:  2007-04-19       Impact factor: 4.506

Review 6.  Current trends in mouse models of glioblastoma.

Authors:  Masafumi Miyai; Hiroyuki Tomita; Akio Soeda; Hirohito Yano; Toru Iwama; Akira Hara
Journal:  J Neurooncol       Date:  2017-10-20       Impact factor: 4.130

7.  Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma.

Authors:  Sarah Meneceur; Annett Linge; Matthias Meinhardt; Sandra Hering; Steffen Löck; Rebecca Bütof; Dietmar Krex; Gabriele Schackert; Achim Temme; Michael Baumann; Mechthild Krause; Cläre von Neubeck
Journal:  Cancers (Basel)       Date:  2020-04-03       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.